webinar recording available - register to watch

Leveraging large-scale mRNA biology data to advance disease understanding

The fusion of artificial intelligence with the intricate world of mRNA biology holds immense potential to revolutionize our understanding of the complex mechanisms underlying mRNA regulation. The pivotal role of large-scale data analysis in this space is increasingly evident. The upcoming webinar will focus on this crucial aspect, particularly on enabling scaled data generation in complex biological systems.

Featured in the webinar are Dr. Iris Alroy, Co-Founder and Chief Scientific Officer at Anima Biotech, the first drug discovery platform company bringing AI to mRNA Biology, and Dr. Gene Yeo, Professor of Cellular and Molecular Medicine at the University of California San Diego (UCSD) and the Founding Director of UCSD’s Center for RNA Technologies and Therapeutics. Together, they will delve into the creation and application of extensive datasets in mRNA biology, discussing how these are driving pioneering research and opening new avenues in drug discovery.

watch now
watch the webinar

No cost to register, subject to confirmation.

By registering for this event, you accept that you may receive direct communication from the sponsor(s) and email marketing about Endpoints News webinars.

If you are experiencing problems with your registration, please try the Zoom registration page.

Iris Alroy

Iris Alroy

Co-Founder and CSO, Anima Biotech

Iris Alroy, Ph.D. has over 25 years of experience in drug discovery, preclinical and early clinical development. Dr. Alroy has served as co-founder and CSO of Anima since 2015, supervising drug discovery and pipeline development in the emerging field of mRNA translation regulation. Prior to Anima, she acted as VP of Discovery at Proteologics and Pharmos Corp. and CEO of several startup biotech companies, including Fusimab, Ltd. and ProMining Therapeutics Ltd. Dr. Alroy earned her doctorate in Cell Biology from Cornell University and completed a post-doctoral fellowship at the Weizmann Institute. She has authored more than 20 scientific articles in peer-reviewed journals.

Gene Yeo

Gene Yeo

Professor, University of California San Diego, Department of Cellular and Molecular Medicine

Gene Yeo, PhD, MBA is a Professor of Cellular and Molecular Medicine at the University of California San Diego, Director for UCSD’s Center for RNA Technologies and Therapeutics, Chief Scientific Advisor for Sanford Laboratories for Innovative Medicine and Director for the Sanford Stem Cell Institute’s Innovation Center. Dr. Yeo is a computational and experimental scientist who studies how RNA processing is regulated by RNA binding proteins in development and disease. Gene has authored over 250 peer-reviewed publications and received numerous academic awards, including the Paul Allen Distinguished Investigatorship (2020), the RNA Society’s Elisa Izaurralde Award for Innovation in Research, Teaching and Service (2021) and the inaugural Academia Europaea Sydney Brenner Medal (2023). Gene has founded several biotech companies and serves as scientific advisor to many, including EclipseBio, Orbital Therapeutics, Insitro, Automera, AmberBio and Atomic.AI. Gene is among the top 50 life science academic entrepreneurs by BIOS’ Beaker List and received the inaugural Entrepreneurial Achievement Award from the Rady School of Management in 2023.

Surani Fernando

Surani Fernando

Healthcare journalist, writer & podcaster

Surani Fernando is a seasoned healthcare journalist and editor with over 13 years experience covering the biopharma industry. A Sydney native, she started her investigative journalism career in London covering clinical trials, M&A and financing deals for BioPharm Insight, later moving to New York to continue her work as an enterprise journalist and editorial leader for GlobalData and Reorg. She is now based in Madrid working as a freelance journalist, consultant writer and podcast producer. In November 2023, she launched the Raising Biotech podcast.